Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Vaccines

Nanorings boost vaccine adjuvant effects

Although CpG oligodeoxynucleotides (ODNs) are useful vaccine adjuvants, optimizing these single-stranded synthetic DNAs to induce the desired immune response is tricky. This paper showed that K-class ODNs could be multimerized into stable nanorings using the HIV-derived peptide Tat. In mice, the nanorings boosted T helper 1 cell-mediated immune responses to a viral antigen, and produced good antitumour immunity when used as a therapeutic tumour vaccine adjuvant. So such ODN nanorings could be used as improved anticancer or antiviral vaccine adjuvants.

References

  1. Gungor, B. et al. CpG ODN nanorings induce IFNα from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity. Sci. Transl. Med. 6, 235ra61 (2014)

    Article  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Harrison, C. Nanorings boost vaccine adjuvant effects. Nat Rev Drug Discov 13, 496 (2014). https://doi.org/10.1038/nrd4380

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4380

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing